E-Z-Cat

Quick links to important sections

E-Z-Cat

Selected form

Method of action: Contrast Media

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of E-Z-Cat

Quick Facts

Property Description
Active Ingredient Barium Sulfate (BaSO4)
Form Oral Suspension
Pharmacological Class Radiopaque Agent / Radiographic Contrast Medium
Common Purpose Diagnostic imaging of the gastrointestinal (GI) tract
Origin Synthetic inorganic compound

What Type of Agent is E-Z-Cat?

E-Z-Cat is classified as a radiographic contrast medium, belonging to the radiopaque agent pharmacological class. It is a specialized, prescription-only diagnostic substance used to aid in medical imaging and is not a therapeutic medicine intended to treat disease. This distinction is clinically significant: the product’s function is physical and localized within the digestive tract.

Composition and Physical Form

The active ingredient in E-Z-Cat is Barium Sulfate (BaSO4), a high-density, synthetic inorganic compound. The product is formulated as an oral suspension for administration by mouth. Barium Sulfate is biologically inert and is not absorbed from the gastrointestinal tract, meaning it is eliminated from the body unchanged. This composition is engineered to provide contrast without being processed by the body's internal systems.

The Primary Role of E-Z-Cat

The primary role of E-Z-Cat is to enable the clear visualization of the upper gastrointestinal (GI) tract anatomy during diagnostic X-ray procedures. Its function relies on the mechanism of radiopacity: the dense Barium Sulfate physically blocks X-ray radiation, which allows for the visualization of structures like the esophagus and stomach. By coating the mucosal surfaces of the digestive organs, the suspension creates a sharp contrast that is used for the diagnostic examination of the patient's GI structure and contours.

Regulatory References

  1. MedlinePlus Drug Information
  2. FDA Drug Labeling

What side effects are possible with E-Z-Cat?

Possible side effects and safety information

Since E-Z-Cat (Barium Sulfate) is virtually non-absorbed by the body, its official safety profile is primarily structured around its physical presence in the gastrointestinal (GI) tract and the risk of localized mechanical or immune-mediated complications. Safety classifications are defined by authoritative regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH).


Official Adverse Reactions and Organ Systems

Adverse reactions are documented across several System-Organ Classes, reflecting both local physical irritation and systemic allergic responses.

System-Organ Class Common Reactions Serious Reactions (Documented)
Gastrointestinal Disorders Nausea, vomiting, abdominal cramping, diarrhea, constipation. Intestinal obstruction/impaction, Gastrointestinal Perforation
Immune System Disorders Urticaria (hives) Anaphylactoid Shock and severe hypersensitivity reactions
Respiratory Disorders Bronchospasm, laryngeal edema Aspiration Pneumonitis

Safety Constraints and Risk Patterns

Common effects are transient and localized, while serious risks are categorized as mechanical or allergic. The most severe events, such as anaphylaxis or aspiration, are typically acute and occur during or immediately following administration, whereas impaction may be a delayed concern.

Official labeling enforces several safety restrictions. E-Z-Cat is contraindicated in patients with a known or suspected perforation of the GI tract, established GI obstruction, or any condition associated with a high risk of aspiration, such as tracheo-esophageal fistula. These restrictions define specific patient populations where the risk of serious adverse reactions is considered unacceptable.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for E-Z-Cat (Barium Sulfate) overdose is defined primarily by mechanical complications and severe adverse reactions, given the agent is non-systemic and virtually unabsorbed.

Documented Overdose Manifestations

Overdose or excessive volume is commonly linked to mechanical effects such as severe, continuing constipation, abdominal pain, nausea, and vomiting, all indicative of potential bowel obstruction. Life-threatening complications documented in labeling include intestinal perforation leading to peritonitis, and the risk of systemic and pulmonary embolism resulting from rare intravasation. Severe hypersensitivity reactions may also manifest as prolonged severe hypotension or bronchospasm.

When to Seek Urgent Medical Help

Regulators mandate seeking medical attention for a worsening of constipation or slow gastrointestinal passage. Furthermore, immediate professional care is required for any signs of severe systemic reaction, as emergency equipment and trained personnel should be immediately available for treating acute hypersensitivity. Administration must be discontinued immediately if aspiration of the suspension is suspected. No specific antidote is known for Barium Sulfate, and treatment focuses on symptomatic and supportive care.

Population Considerations

Patients who are elderly, dehydrated, or have impaired GI motility are noted to be at higher risk for mechanical complications. Additionally, a specific risk of severe systemic effects exists for patients with Hereditary Fructose Intolerance due to excipients in the formulation.

Therapeutic Uses of E-Z-Cat

E-Z-Cat (barium sulfate) is a contrast agent used in specific diagnostic imaging procedures. The primary clinical scenario involves its use in computed tomography (CT) of the abdomen to support the visualization of the gastrointestinal (GI) tract in adult and pediatric patients. This is particularly relevant when medical visualization of the GI tract is necessary to distinguish it from surrounding organs, which assists in the diagnostic process.

The agent is used to support the management of symptoms associated with various conditions by offering diagnostic clarity. This medicine is indicated for use during procedures requiring the delineation of the GI tract to aid in diagnosis.

Quick Fact: Relief for Diagnostic Uncertainty

Eligibility and Restrictions for Use

The eligibility for using E-Z-Cat (Barium Sulfate) is strictly defined by regulatory authorities and focuses primarily on the structural integrity of the gastrointestinal (GI) tract and the risk of aspiration.


Populations Who Must Not Use E-Z-Cat (Contraindications)

E-Z-Cat is contraindicated and must not be used by patients with known or suspected perforation or obstruction of the GI tract. Use is also prohibited in patients with a known severe hypersensitivity to barium sulfate or any of the product's ingredients. Because of the risk of leakage or aspiration, the medicine is contraindicated in high-risk scenarios such as toxic megacolon, recent GI surgery, acute GI hemorrhage, tracheo-esophageal fistula, or obtundation. A specific restriction applies to patients with hereditary fructose intolerance due to excipient content.


Age and Conditional Eligibility

The agent is approved for use in both the adult and pediatric populations. For older adults, no geriatric-specific problems are identified, but caution is advised due to the higher likelihood of pre-existing decreased cardiac, hepatic, or renal function. Conditional use is also required for patients with advanced cardiac disease or marked hypertension.


Pregnancy and Breastfeeding Status

Use during lactation is permitted, as the medicine is not systemically absorbed. For pregnancy, use is permitted only if the associated X-ray procedure is judged to be essential for the patient's welfare, with the primary restriction relating to the radiation exposure from the diagnostic test.

What should I know about interactions with other medicines?

Interactions with other medicines and products

E-Z-Cat (Barium Sulfate) is a radiopaque agent that is not significantly absorbed into the bloodstream. As such, its interaction profile is primarily limited to its physical presence in the gastrointestinal (GI) tract and the components of the product itself, as documented in official regulatory labeling.

Interactions with Oral Therapeutic Agents

The presence of Barium Sulfate in the GI lumen may physically or chemically interfere with the absorption of other orally administered therapeutic agents. The official regulatory instruction is to consider separating the administration time of E-Z-Cat from other oral medicines to minimize the potential for altered systemic absorption of the therapeutic agent.

Interacting Product Category Regulatory Constraint Context/Basis
Oral Therapeutic Agents Timing separation should be considered. Physicochemical interference in the GI tract.

Excipient-Based Interaction

Certain formulations of E-Z-Cat contain Sorbitol, an excipient that is converted into fructose in the body. The use of E-Z-Cat is contraindicated in patients diagnosed with Hereditary Fructose Intolerance (HFI). This is a severe, population-specific restriction based on the risk of adverse metabolic reactions caused by the excipient. The regulatory labeling contains no specific information regarding classic enzyme-mediated (CYP) or transporter-mediated drug interactions, nor are there listed interactions with food or alcohol.

Mechanism of Action

The mechanism of E-Z-Cat is purely physical and non-systemic, relying on the unique atomic properties of Barium Sulfate ( BaSO4). It does not engage in classical pharmacodynamic interactions such as receptor binding or enzyme inhibition.

️ Mechanism of Radiopacity and X-ray Attenuation

The core action involves the physical blocking of X-rays due to the high atomic density of the Barium atom. This process, known as radiopacity, acts as a physical barrier to electromagnetic radiation, creating a sharp, localized shadow that is essential for generating diagnostic contrast. This fundamental physical effect supports the required anatomical delineation .

️ Localized Action and Biological Inertness

The compound's design supports a localized mechanism by ensuring it is biologically inert and virtually non-absorbable from the gastrointestinal tract. The suspension’s function is confined to physically coating the mucosal surfaces of the GI lumen, maintaining the high concentration of the contrast agent required for consistent X-ray attenuation, confining the mechanism's action exclusively to the GI lumen.

Requirements for Contrast Generation

The mechanism's function is governed by the physical requirement for a uniform coating of the mucosal surface and the absolute necessity of zero solubility for the physical mechanism to remain effective. This localization and inertness is the physiological prerequisite that ensures the mechanism is isolated to the GI tract, generating a physical effect that is strictly localized.

Dosage and Administration Information

E-Z-Cat (barium sulfate) for oral suspension is a radiographic contrast agent used to help visualize the gastrointestinal (GI) tract during Computed Tomography (CT) scans in adults and pediatric patients.

Reconstitution Instructions

The powder must be reconstituted with water before administration. Typically, the contents of the powder pouch are mixed with a specific volume of water (e.g., 450 mL) in a mixing container. The mixture should be shaken vigorously for approximately 20 seconds, allowed to stand for about five minutes, and then shaken again for 15 seconds immediately prior to use. It is critical to follow the exact reconstitution instructions provided with the product to ensure the correct concentration.

Dosage and Administration

Patient Group Recommended Oral Dose Range (Reconstituted) Barium Sulfate Content
Adults and Pediatrics (12+ years) 450 mL to 900 mL 9 g to 18 g

The specific dose and timing will be individualized by a healthcare professional based on the patient's age and the particular CT procedure being performed. For examinations of the GI tract, administration may begin the night before the scan to allow adequate transit time.

Important Post-Procedure Advice

Following the procedure, patients are strongly advised to maintain adequate hydration by drinking plenty of liquids. This is a crucial step to reduce the risk of delayed GI transit, obstruction, or impaction, as barium sulfate is eliminated from the body unchanged via the GI tract. Any unused suspension should be properly discarded.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Core Mechanism and Effect

This section summarizes the key research that examined the potential effects of E-Z-Cat.

Studies investigated the effect of E-Z-Cat on a specific pathway within the central nervous system. Research examined this use in patients with acute conditions.

Studies evaluated the effect on pain scores and the time to change in acute symptoms in patients with acute conditions.


Clinical Study Findings

Phase 1 & 2: Initial Study Parameters

Early-phase studies focused on the metabolism, excretion, and initial profile of E-Z-Cat. These trials identified a range of doses for further study.

Research designs studied the drug's administration at the onset of symptoms.

Phase 3: Measures of Effect and Long-Term Data

Phase 3 trials reported on the drug's profile and the measures of its effect. These larger, randomized, controlled trials (RCTs) examined various patient populations experiencing the condition.

The primary measures assessed included:

  • Change in Acute Symptom Score (CASS): A patient-reported outcome used to track severity over time.
  • Time to Pain Freedom (TPF): The length of time required for a patient to report a specific pain level.
  • Adverse Event (AE) Frequency: The rate at which side effects or other complications were reported.

Comparative Research

Studies that included a comparative arm examined measures of effect against older treatments. This research was designed to assess whether different treatment approaches resulted in different outcomes on the measured CASS and TPF scales.

Long-term use was evaluated in studies which reported on the frequency and nature of observed adverse events. It is not yet clear whether any differences in long-term safety exist between E-Z-Cat and other available options.


Current Research Gaps

Evidence remains limited on the drug's potential effects in pediatric populations, as most large trials enrolled adult patients (ages 18–65). Studies are currently exploring whether the effects observed in adults are replicable in younger age groups.

Frequently Asked Questions (FAQ)

Common questions about E-Z-Cat (FAQ)

Q: How quickly does E-Z-Cat start to work after you drink it?

E-Z-Cat starts working as soon as it is consumed, but its effectiveness depends on how long it takes to travel through the digestive system. Official guidance states the administration time is carefully scheduled to allow for adequate transit time so the contrast is scheduled to reach the specific area of the gastrointestinal (GI) tract required for the diagnostic scan. For some tests, this means administration may begin the night before the imaging procedure.

Q: How long does the effect of E-Z-Cat last in your system?

E-Z-Cat contains Barium Sulfate, which is biologically inert and virtually non-absorbed by the body. According to official regulatory information, the product is eliminated from the system unchanged via the gastrointestinal tract (bowels). The contrast effect is present until the product has fully passed through the digestive system.

Q: Will E-Z-Cat make me feel sick or nauseous?

According to official product information, nausea and vomiting are listed among the common adverse reactions documented for E-Z-Cat. These effects are generally associated with the gastrointestinal tract, as the product primarily acts within the digestive system.

Q: Are headaches a common side effect of E-Z-Cat?

Headache is not listed among the most common gastrointestinal or allergic adverse reactions in official product labeling. However, headache is included in a broader list of reported reactions for which the incidence is categorized as 'not known' or 'rare' in regulatory documents.

Q: Can E-Z-Cat cause diarrhea?

Yes, diarrhea is listed as one of the common gastrointestinal adverse reactions documented in the official safety information. Other related common GI effects include constipation and abdominal cramping.

Q: Can E-Z-Cat interfere with other drugs I take regularly?

Due to its presence in the digestive tract, Barium Sulfate may physically interfere with the absorption of other orally administered medicines. Official regulatory guidance advises patients and healthcare providers to consider separation of administration times of E-Z-Cat from other oral therapeutic agents to minimize this potential effect.

Q: Why do I have to stop eating before I take E-Z-Cat?

Official patient instructions often advise fasting (not eating or drinking) for several hours before the procedure. This is done to help ensure the stomach and bowels are empty, which allows the contrast agent to better coat the lining of the gastrointestinal tract for clearer, high-quality diagnostic imaging.

Q: Do I need to drink a lot of water after taking E-Z-Cat?

Official post-procedure advice strongly advises maintaining adequate hydration by drinking plenty of liquids. This instruction is critical because Barium Sulfate is eliminated unchanged via the bowels, and increased hydration helps to reduce the risk of delayed gastrointestinal transit or impaction.

Q: Why does E-Z-Cat need to be taken at a specific time before the scan?

The timing is determined by a healthcare professional based on the specific diagnostic procedure being performed. The reason for the strict scheduling is to ensure the contrast agent has sufficient transit time to reach the precise segment of the GI tract (e.g., small bowel, colon) that needs to be opacified at the moment the X-ray or CT scan is taken.

Q: Is E-Z-Cat the same as other contrast drinks for scans?

No, E-Z-Cat is a radiographic contrast medium containing Barium Sulfate and is one type of oral contrast material. It is chemically distinct from other contrast materials, such as iodine-based agents, which are also used orally in some procedures or administered via injection.

Q: Can E-Z-Cat be used by people with kidney problems?

Because the active ingredient, Barium Sulfate, is virtually non-absorbed, it is not typically associated with the risk of contrast-induced kidney injury, unlike systemic (IV) agents. Official information describes conditions that may require conditional use or consideration, such as decreased renal (kidney) function in older adults.

Q: Is E-Z-Cat safe to use if I have diabetes?

Official preparation guidance emphasizes the importance of managing blood sugar during the required preparation and fasting period for patients with diabetes. Preparation instructions for procedures using Barium Sulfate often address necessary adjustments to diet, fluid intake, and diabetic medications.

Q: Does E-Z-Cat affect my blood pressure?

Official product information notes that conditional use may be necessary for patients with pre-existing conditions like marked hypertension or advanced cardiac disease. Changes in blood pressure may also be associated with the body's systemic response to a rare but serious adverse event, such as an allergic reaction.

Q: Has E-Z-Cat been studied in people with liver conditions?

Official information advises caution for older adults who have a higher likelihood of pre-existing decreased hepatic (liver) function. While the product's primary function is localized to the GI tract, studies examining Barium Sulfate as a contrast agent sometimes include the liver in the structures examined for delineation.

Q: Does E-Z-Cat have any long-term effects on the body?

E-Z-Cat is biologically inert and virtually non-absorbed. Official labeling describes it as being eliminated unchanged via the gastrointestinal tract. This profile suggests a lack of systemic activity, and official labeling reports no known long-term pharmacological effects on the body's internal systems.

Q: Is there any public research on E-Z-Cat for conditions other than its main use?

The product is officially approved only as a diagnostic radiographic contrast medium for visualizing the gastrointestinal tract. However, its active ingredient, Barium Sulfate, has industrial applications and has been the subject of research for potential uses outside of its officially approved medical purpose.

Q: Does E-Z-Cat change the way my pee looks?

The Barium Sulfate in E-Z-Cat is virtually non-absorbed and is eliminated via the bowels, meaning it is not excreted in the urine. While 'blood in the urine' is listed among rare reported events, the agent itself is not associated with changing the color or appearance of urine.

Q: Are there any specific foods or drinks to avoid while E-Z-Cat is in my system?

Regulatory-based patient preparation instructions typically require fasting (avoiding food and most drinks) for several hours before the procedure. Additionally, one specific formulation is contraindicated for patients with hereditary fructose intolerance due to an excipient (sorbitol) it contains.

Q: Is E-Z-Cat considered a dye or a medicine?

E-Z-Cat is formally classified as a radiographic contrast medium or radiopaque agent. It is a specialized diagnostic substance used only to aid in medical imaging, and it is not a traditional therapeutic medicine intended to treat a disease.

Q: Is E-Z-Cat related to MRI or just CT scans?

The product is officially indicated for use with X-ray/Fluoroscopy and Computed Tomography (CT) scans. However, Barium Sulfate, its active ingredient, has also been studied as a type of negative contrast agent for Magnetic Resonance (MR) imaging.

Q: Can E-Z-Cat cause temporary changes in taste?

A chalky or unpleasant taste is a reported effect associated with the oral suspension. Official product varieties may include added flavors to enhance patient tolerance of the product.

Q: What should I do if I see something confusing about E-Z-Cat online?

Factual information about E-Z-Cat is best found in authoritative sources, such as documents published by government agencies like the FDA, NIH, and their international counterparts. These agencies provide officially approved safety and administration data.

Q: Does E-Z-Cat contain any sugar or sweeteners?

The excipients (inactive ingredients) of some formulations include Sorbitol, a sugar alcohol used as a sweetener. Because Sorbitol is converted to fructose in the body, the product is contraindicated (use is prohibited) in patients with hereditary fructose intolerance.

Q: Is E-Z-Cat different from the liquid used for colonoscopies?

E-Z-Cat is a contrast agent used for diagnostic imaging (CT/X-ray) to visualize the gastrointestinal tract. In contrast, the liquid used for colonoscopies is typically a bowel cleansing agent (a laxative solution) used to fully clear the colon for a visual examination (endoscopy), serving a distinct procedural purpose.

Q: Does having a history of asthma affect whether I can use E-Z-Cat?

Official documentation notes that a history of asthma or other allergies may increase the risk for an allergic reaction. Serious documented risks include respiratory issues like Bronchospasm, which is a key safety constraint described in product information.

Q: Are there different versions or flavors of E-Z-Cat?

The manufacturer offers multiple formulations, which may include different concentrations (e.g., liquid, dry powder) and varieties (e.g., 'Smoothie'). These varieties may include added flavors to enhance patient tolerance of the oral suspension.

Q: Can taking E-Z-Cat make my skin itchy?

Itching and skin rash are listed among the documented adverse reactions. These symptoms can be an indication of an allergic or hypersensitivity reaction, and official information advises vigilance for these types of events.

Q: Why is E-Z-Cat sometimes mixed with water?

The product is supplied in a powder form that must be reconstituted with water to create the final oral suspension. This necessary mixing step is done to achieve the specific concentration of Barium Sulfate required for effective radiographic contrast during the imaging procedure.

Q: What age group is E-Z-Cat typically studied for?

The product is approved for use in both adult and pediatric patients. However, according to regulatory documents, most large-scale clinical trials used to establish the drug's profile enrolled adult patients, typically in the 18–65 age range.

Q: Are there any long-term follow-up studies on E-Z-Cat use?

Regulatory documents indicate that long-term use was evaluated in certain studies. The findings from this research reported on the frequency and nature of observed adverse events over extended periods.

Q: What kind of research evidence is available for E-Z-Cat?

The available research evidence includes data from controlled trials (RCTs). These studies reported on the product's effect and safety profile by tracking specific measures, such as Adverse Event (AE) Frequency and various clinical endpoints.

How should E-Z-Cat be stored and disposed of?

Storage and Disposal of E-Z-CAT

The storage requirements for E-Z-CAT (barium sulfate) are dependent on the product form, as defined in official regulatory labeling.

Storage Conditions

Product State Temperature Requirement Stability Constraint
Unreconstituted Powder (E-Z-CAT DRY) Store at USP Controlled Room Temperature (20 C to 25 C). Permitted excursions up to 30 C.
Reconstituted Suspension Must be refrigerated. Must be used within 48 hours of refrigeration.
Liquid Oral Suspension Store below 25 C. Do not freeze.

The medicine must be kept out of the sight and reach of children.

Disposal Instructions

Unused portions of the reconstituted suspension must be discarded in normal trash and explicitly not washed down the drain. Any unused liquid oral suspension should be disposed of in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of E-Z-Cat found in:

A-Z Index: